Skip to content
New: the free AppMetis browser extension puts measured installs and chart places on every Google Play and App Store page →
AppMetis
Google PlayFree

AG946 C 003

THREAD Medical 🇺🇸 United States

Participant app for the AG946 C 003 study

Installs
18
Measured
Rating
—
Ratings
—
Version
Varies with device
Released
24 Mar 2025
Tracked since 13 May 2026
Size
—

Screenshots

AG946 C 003 screenshot 1AG946 C 003 screenshot 2AG946 C 003 screenshot 3AG946 C 003 screenshot 4AG946 C 003 screenshot 5

About AG946 C 003

The description on the store listing

This app is intended for use by participants in the AG946 C 003 study and requires an invitation and activation code from the study site to register. A Phase 2, Double-blind, Randomized, Placebo-Controlled, Multicenter, Dose-Finding, Efficacy, and Safety Study of Tebapivat in Subjects with Sickle Cell Disease. This study has been reviewed and approved by the appropriate regulatory body, e.g. Institutional Review Board (IRB) or Independent Ethics Committee (IEC). Key App Features: - Patient Onboarding – complete study app registration and education - Activities – on-demand study tasks and assessments are sent from the site to the participant - Dashboard – review overall progress in …

Read the full description

This app is intended for use by participants in the AG946 C 003 study and requires an invitation and activation code from the study site to register. A Phase 2, Double-blind, Randomized, Placebo-Controlled, Multicenter, Dose-Finding, Efficacy, and Safety Study of Tebapivat in Subjects with Sickle Cell Disease. This study has been reviewed and approved by the appropriate regulatory body, e.g. Institutional Review Board (IRB) or Independent Ethics Committee (IEC). Key App Features: - Patient Onboarding – complete study app registration and education - Activities – on-demand study tasks and assessments are sent from the site to the participant - Dashboard – review overall progress in the study and current activities - Resources – view study information in the Learn section of the app - Profile – manage account details and app settings - Notifications – receive in-app reminders About THREAD: THREAD’s® purpose is to leverage its clinical research platform to enable studies for everyone, everywhere. The company’s uniquely combined clinical research technology and consulting services help life science organizations to design, operate, and scale next-generation research studies and electronic clinical outcome assessments (eCOA) programs for participants, sites, and study teams. Through its comprehensive platform and scientific expertise, THREAD empowers studies to be accessible, efficient, and centered on the patient.

Installs since 15 Nov 2026 Measured

Exact Google Play install counts, collected daily

Updated 7 d ago

Daily history starts once this app is in our daily install sample.

Full history, growth rates and exports are in AppMetis.Start free

Ratings

  • 5 ★0.0%
  • 4 ★0.0%
  • 3 ★0.0%
  • 2 ★0.0%
  • 1 ★0.0%

Recent reviews

Latest public reviews from the store

  • 16 Dec 2024

    There's a huge glitch that won't let me past the insurance survey

  • 18 Jan 2020

    Good

Top chart positions

Latest Google Play chart ranks by country, last 10 days

Not in any tracked top chart in the last 10 days.

AG946 C 003 history

Release, install milestones, listing and store changes

  1. First released on the store 24 Mar 2025

Update frequency

How often AG946 C 003 ships a new version, month by month

DecJanFebMarAprMayJunJulAugSepOctNov

0 updates in the last 12 months. Less often than most similar apps: they shipped a median of 1 updates in the same year.

Listing keywords

Words and phrases AG946 C 003 repeats most in its store listing

study10ag9463clinical3research3studies3activities2assessments2participant2participants2patient2platform2review2site2thread2

Top phrases: ag946 study (2), clinical research (2).

Highlighted words also appear in the title. Counts cover the title, short description and description.

Business model and tech

From the store listing and declared permissions

Business model
Free to download
Sensitive access
No sensitive permission declared

Compliance

What the listing and the app package show

Store status
Live
Registered in
United States
Privacy policy
Linked on the listing
Advertising
No ads declared
In-app purchases
None declared
Age rating
Everyone

Apps like AG946 C 003

AG946 C 003: questions and answers

How many downloads does AG946 C 003 have?

AG946 C 003 has 18 installs on Google Play, measured from the store's own count on 15 Nov 2026.

Who makes AG946 C 003?

AG946 C 003 is published by THREAD, a developer based in US.

Is AG946 C 003 free?

Yes. AG946 C 003 is free to download.

Is AG946 C 003 still available?

Yes. AG946 C 003 is live on Google Play as of 15 Nov 2026.

Track AG946 C 003 and its competitors

Watch any app for new versions, rating drops, chart moves and removals. Free plan, no card.